Novartis AG (NVSEF)
97.97
-1.51
(-1.52%)
USD |
OTCM |
May 31, 16:00
Novartis Total Assets (Quarterly): 94.33B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 94.33B |
December 31, 2023 | 99.94B |
September 30, 2023 | 112.70B |
June 30, 2023 | 110.98B |
March 31, 2023 | 112.24B |
December 31, 2022 | 117.45B |
September 30, 2022 | 118.46B |
June 30, 2022 | 122.91B |
March 31, 2022 | 125.22B |
December 31, 2021 | 131.80B |
September 30, 2021 | 121.21B |
June 30, 2021 | 124.02B |
March 31, 2021 | 121.75B |
December 31, 2020 | 127.78B |
September 30, 2020 | 129.68B |
June 30, 2020 | 123.76B |
March 31, 2020 | 123.10B |
December 31, 2019 | 118.37B |
September 30, 2019 | 115.97B |
June 30, 2019 | 116.29B |
March 31, 2019 | 137.95B |
December 31, 2018 | 145.56B |
September 30, 2018 | 142.99B |
June 30, 2018 | 142.06B |
March 31, 2018 | 135.52B |
Date | Value |
---|---|
December 31, 2017 | 133.08B |
September 30, 2017 | 134.97B |
June 30, 2017 | 133.75B |
March 31, 2017 | 131.99B |
December 31, 2016 | 130.12B |
September 30, 2016 | 134.01B |
June 30, 2016 | 131.44B |
March 31, 2016 | 132.45B |
December 31, 2015 | 131.56B |
September 30, 2015 | 132.93B |
June 30, 2015 | 135.41B |
March 31, 2015 | 134.94B |
December 31, 2014 | 125.39B |
September 30, 2014 | 125.38B |
June 30, 2014 | 125.77B |
March 31, 2014 | 125.33B |
December 31, 2013 | 126.25B |
September 30, 2013 | 124.59B |
June 30, 2013 | 121.07B |
March 31, 2013 | 121.01B |
December 31, 2012 | 124.19B |
September 30, 2012 | 121.22B |
June 30, 2012 | 118.49B |
March 31, 2012 | 119.41B |
December 31, 2011 | 117.50B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
94.33B
Minimum
Mar 2024
131.80B
Maximum
Dec 2021
118.40B
Average
119.84B
Median
Total Assets (Quarterly) Benchmarks
Sandoz Group AG | -- |
Roche Holding AG | 107.71B |
ADC Therapeutics SA | 307.97M |
AC Immune SA | 185.40M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 54.58B |
Shareholders Equity (Quarterly) | 39.68B |
Debt to Equity Ratio | 0.6435 |
Current Ratio | 0.903 |
Net Debt Paydown Yield | 0.06% |